Target intelligence / Profile preview

Gastrointestinal and respiratory mucosa

Molecular classification
Other
01

Overview

The gastrointestinal and respiratory mucosae are specialized tissue layers that line the internal tracts of the body, serving as the primary interface between the internal environment and external agents (StatPearls, 2023). These mucosal surfaces consist of epithelial cells, underlying connective tissue known as the lamina propria, and often a layer of smooth muscle, providing critical barrier, absorptive, and secretory functions (NIH, 2021). In the respiratory tract, the mucosa facilitates gas exchange and traps pathogens via mucus and cilia, while the gastrointestinal mucosa manages nutrient uptake and maintains a complex immunological tolerance to food and microbiota (PubMed, 2022). While not a single molecular target, the mucosa is a major site for drug delivery and the focus of treatments for conditions like inflammatory bowel disease, asthma, and various infections (Nature Reviews Drug Discovery, 2020). Therapeutic interventions often aim to enhance barrier integrity, modulate local immune responses, or provide physical protection to the epithelial surface.

Other names
Mucous membraneMucosal liningGastrointestinal epitheliumRespiratory epitheliumMucosa
02

Mechanism of action

Drugs acting on these tissues typically provide physical protection (cytoprotection), reduce local inflammatory cytokine production, or modulate the activity of mucosa-associated lymphoid tissue (MALT) to restore barrier integrity (StatPearls, 2023).

03

Biological functions

Barrier functionImmune responseAbsorptionSecretionMucociliary clearance
04

Disease associations

InfectionInflammationCancerAsthmaInflammatory bowel diseaseCystic fibrosis
05

Safety considerations

Mucosal atrophyDisruption of the commensal microbiomeSystemic absorption of locally intended agentsImpaired local immune defense
06

Interacting drugs

Sucralfate

5 more in the full profile.

07

Biomarkers

Fecal calprotectinFractional exhaled nitric oxide (FeNO)Mucin expression levelsSecretory IgA

Beyond the preview

Go deeper on Gastrointestinal and respiratory mucosa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal and respiratory mucosa.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call